Skip to content
healthcare.dev

Topiramate

NDC 10370-368, Topiramate, capsule, extended release, from Par Health USA, LLC.

Product NDC
10370-368
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205976
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10370-368 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
10370-368-0110370036801100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-01)
10370-368-111037003681130 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9ac09563-5967-498c-93ae-675a7f4efc48
  • NADAC price for package 10370036801

    GET /v1/drugs/nadac/10370036801
  • NADAC price for package 10370036811

    GET /v1/drugs/nadac/10370036811

Use it

Look up 10370-368 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10370-368 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10370-368. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.